warnings
WARNINGS For external use only. Not for ophthalmic use. Avoid contact with eyes. Excessive application may result in increased systemic absorption. Keep out of reach of children.
Numyra
openFDA label record#
This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.
Verified complete openFDA source JSON
- Brand name
- Numyra
- Generic name
- NUMYRA
- Manufacturer
- Oncora Pharma, LLC
- Product type
- HUMAN PRESCRIPTION DRUG
- SPL set ID
- 8707143f-dfd0-40b4-9594-9b2c569c3270
- SPL ID
- 6d953a59-a118-4535-a3cb-e71e6a531ffb
- Version
- 2
- Effective date
- 2026-08-27
- Source export date
- 2026-09-28
- Source partition
- 8
- Source file
- https://download.open.fda.gov/drug/label/drug-label-0008-of-0014.json.zip
- Source object key
- raw/openfda/drug-label/2026-09-28/ae3816359e336a5de4f44607730a3d12ceb61ffa012a132189ceda22541b38ee/drug-label-0008-of-0014.json.zip
- Source manifest SHA-256
- cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
- Import run
- 20260929T050834Z
- Imported at
- 2026-09-29 05:56:16
| Harmonized routes |
|---|
| TOPICAL |
Harmonized identifier links#
Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.
| Type | Scope | Identifier | Source field |
|---|---|---|---|
| brand name | Numyra | openfda.brand_name | |
| generic name | NUMYRA | openfda.generic_name | |
| manufacturer name | Oncora Pharma, LLC | openfda.manufacturer_name | |
| ndc | package | 85477-312-07 | openfda.package_ndc |
| ndc | product | 85477-312 | openfda.product_ndc |
| ndc11 | package | 85477031207 | derived:openfda.package_ndc |
| spl id | 6d953a59-a118-4535-a3cb-e71e6a531ffb | id | |
| spl set id | 8707143f-dfd0-40b4-9594-9b2c569c3270 | set_id | |
| unii | 98PI200987 | openfda.unii |
Warnings cross-check#
openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.